ANDASUBLINGUALTABLET
Approved
Dec 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
buprenorphine, a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor.
Indications (1)
Clinical Trials (1)
Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
Started Sep 2005
52 enrolled
Opioid Dependency